Coherus Oncology CHRS
NASDAQ CHRS
$0.77 +0.02 (+2.82%)
At close: Nov 6, 2026 · 4:00 PM EST

Coherus Oncology (CHRS) Change in Intangibles (2024)

Updated

Coherus Oncology (CHRS) reported Change in Intangibles of $187.82 million for Q1 2024.

Analysis

Coherus Oncology (CHRS) Change in Intangibles (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Intangibless (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.06 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn 995.00 Mn
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn -
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn -
5 Novartis Ag 315.51 Bn 288.75 Bn - -
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn -7.20 Bn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn -
10 Coherus Oncology 119.30 Mn -516.84 Mn 10.07 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -187.82 Mn
API Access

Coherus Oncology Change in Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-intangibles&ticker=CHRS&period=max&api_key=YOUR_API_KEY